INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 86 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2017 | $11,000 | -68.6% | 5,998 | -65.7% | 0.00% | -66.7% |
| Q1 2017 | $35,000 | +20.7% | 17,474 | +273.5% | 0.00% | 0.0% |
| Q4 2016 | $29,000 | +314.3% | 4,679 | +439.1% | 0.00% | +200.0% |
| Q2 2016 | $7,000 | -30.0% | 868 | -34.9% | 0.00% | 0.0% |
| Q1 2016 | $10,000 | -69.7% | 1,333 | -54.1% | 0.00% | -80.0% |
| Q4 2015 | $33,000 | +1000.0% | 2,901 | +900.3% | 0.01% | – |
| Q3 2015 | $3,000 | – | 290 | +190.0% | 0.00% | – |
| Q2 2015 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
| RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
| Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
| NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
| FT Options LLC | 26,421 | $299,000 | 0.22% |
| EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
| Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |